D.J. St. Germain’s Guardant Health GH Stock Holding History

D.J. St. Germain’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,479	Closed	-$155K	–	943
2025 Q3	$155K	Buy	+2,479	New	+$135K	0.01%	342

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.J. St. Germain's GH Position: Q4 2025 in Review

D.J. St. Germain sold out of Guardant Health (GH) in Q4 2025, closing a stake of 2,479 shares — an estimated $155K sold.

D.J. St. Germain first reported a position in GH in Q3 2025 and held it in 1 quarter. The position peaked at $155K in Q3 2025. 497 funds tracked by Wall St. Rank hold GH as of Q4 2025.

D.J. St. Germain reported no remaining Guardant Health position as of Q4 2025 after selling out during the quarter.
D.J. St. Germain sold 2,479 Guardant Health shares in Q4 2025, an estimated $155K.
D.J. St. Germain first reported a position in Guardant Health in Q3 2025 and held it in 1 quarter.
D.J. St. Germain's Guardant Health position peaked at $155K in Q3 2025.
497 funds tracked by Wall St. Rank held Guardant Health as of Q4 2025.

Based on D.J. St. Germain's 13F filing for Q4 2025, filed 29 Jan 2026.